However, an awareness of the mechanisms more directly detrimental to ganglion cell survival can help tailor pharmacological approaches for successful therapies in the future.

Acknowledgements

This work was supported by NIH grants EY013434 and EY015537 to CHM. The authors thank Alan M. Laties for useful discussions.

References

Adachi, K., Fujita, Y., Morizane, C., Akaike, A., Ueda, M., Satoh, M., Masai, H., Kashii, S., and Honda, Y. (1998). Inhibition of NMDA receptors and nitric oxide synthase reduces ischemic injury of the retina. Eur. J. Pharmacol. 350, 53–57.

AGIS. (2000). The Advanced Glaucoma Intervention Study (AGIS): 7. The relationship between control of intraocular pressure and visual field deterioration. The AGIS Investigators. Am. J. Ophthalmol. 130, 429–440.

Anderson, R. S., and O’Brien, C. (1997). Psychophysical evidence for a selective loss of M ganglion cells in glaucoma. Vis. Res. 37, 1079–1083.

Andrews, R. M., GriYths, P. G., Johnson, M. A., and Turnbull, D. M. (1999). Histochemical localisation of mitochondrial enzyme activity in human optic nerve and retina. Br. J. Ophthalmol. 83, 231–235.

Ansari, E. A., Morgan, J. E., and Snowden, R. J. (2002). Psychophysical characterisation of early functional loss in glaucoma and ocular hypertension. Br. J. Ophthalmol. 86, 1131–1135.

Asrani, S., Zeimer, R., Wilensky, J., Gieser, D., Vitale, S., and Lindenmuth, K. (2000). Large diurnal fluctuations in intraocular pressure are an independent risk factor in patients with glaucoma. J. Glaucoma 9, 134–142.

Bach, M., Unsoeld, A. S., Philippin, H., Staubach, F., Maier, P., Walter, H. S., Bomer, T. G., and Funk, J. (2006). Pattern ERG as an early glaucoma indicator in ocular hypertension: A long term, prospective study. Invest. Ophthalmol. Vis. Sci. 47, 4881–4887.

Brandle, U., Kohler, K., and Wheeler Schilling, T. H. (1998). Expression of the P2X7 receptor subunit in neurons of the rat retina. Brain Res. Mol. Brain Res. 62, 106–109.

Burnstock, G. (1999). Release of vasoactive substances from endothelial cells by shear stress and purinergic mechanosensory transduction. J. Anat. 194, 335–342.

Burnstock, G., Campbell, G., Satchell, D., and Smythe, A. (1970). Evidence that adenosine triphosphate or a related nucleotide is the transmitter substance released by non adrenergic inhibitory nerves in the gut. Br. J. Pharmcol. 40, 668–688.

Carter Dawson, L., Crawford, M. L., Harwerth, R. S., Smith, E. L., 3rd, Feldman, R., Shen, F. F., Mitchell, C. K., and Whitetree, A. (2002). Vitreal glutamate concentration in monkeys with experimental glaucoma. Invest. Ophthalmol. Vis. Sci. 43, 2633–2637.

Cepurna, W. O., Jia, L., Johnson, E. C., and Morrison, J. C. (2006). Aging increases susceptibility to intraocular pressure (IOP) and alters retinal gene expression responses in the rat.

Invest. Ophthalmol. Vis. Sci. 47, 1243. (abs).

Choi, D. W. (1988). Calcium mediated neurotoxicity: Relationship to specific channel types and role in ischemic damage. Trends Neurosci. 11, 465–469.

Clapham, D. E. (1994). Direct G protein activation of ion channels? Ann. Rev. Neurosci. 17, 441–464.

CNTG. (1998). Comparison of glaucomatous progression between untreated patients with normal tension glaucoma and patients with therapeutically reduced intraocular pressures.

Am. J. Ophthalmol. 126, 487–497.

Dacey, D. M. (1993). The mosaic of midget ganglion cells in the human retina. J. Neurosci. 13, 5334–5355.

Dacey, D. M. (1994). Physiology, morphology and spatial densities of identified ganglion cell types in primate retina. Ciba Found. Symp. 184, 12–28.

Daines, B. S., Kent, A. R., McAleer, M. S., and Crosson, C. E. (2003). Intraocular adenosine levels in normal and ocular hypertensive patients. J. Ocul. Pharmacol. Ther. 19, 113–119.

Desatnik, H., Quigley, H. A., and Glovinsky, Y. (1996). Study of central retinal ganglion cell loss in experimental glaucoma in monkey eyes. J. Glaucoma 5, 46–53.

Dolphin, A. C. (2003). G protein modulation of voltage gated calcium channels. Pharmacol. Rev. 55, 607–627.

Dreyer, E. B., Zurakowski, D., Schumer, R. A., Podos, S. M., and Lipton, S. A. (1996). Elevated glutamate levels in the vitreous body of humans and monkeys with glaucoma. Arch. Ophthalmol. 114, 299–305.

Estevez, A. G., Spear, N., Manuel, S. M., Barbeito, L., Radi, R., and Beckman, J. S. (1998). Role of endogenous nitric oxide and peroxynitrite formation in the survival and death of motor neurons in culture. Prog. Brain Res. 118, 269–280.

Ethier, C. R. (2006). Hydrostatic pressure is not a surrogate for IOP in glaucoma. Invest. Ophthalmol. Vis. Sci. E letterhttp://www.iovs.org/cgi/eletters/46/48/2829.

Fleischhauer, J. C., Mitchell, C. H., Peterson Yantorno, K., Coca Prados, M., and Civan, M. M. (2001). PGE(2), Ca(2þ), and cAMP mediate ATP activation of Cl( ) channels in pigmented ciliary epithelial cells. Am. J. Physiol. Cell Physiol. 281, C1614–C1623.

Geyer, O., Almog, J., Lupu Meiri, M., Lazar, M., and Oron, Y. (1995). Nitric oxide synthase inhibitors protect rat retina against ischemic injury. FEBS Lett. 374, 399–402.

Ghiardi, G. J., Gidday, J. M., and Roth, S. (1999). The purine nucleoside adenosine in retinal ischemia reperfusion injury. Vis. Res. 39, 2519–2535.

GiuVrida, S., Bucolo, C., and Drago, F. (2003). Topical application of a nitric oxide synthase inhibitor reduces intraocular pressure in rabbits with experimental glaucoma. J. Ocul. Pharmacol. Ther. 19, 527–534.

Glovinsky, Y., Quigley, H. A., and Dunkelberger, G. R. (1991). Retinal ganglion cell loss is size dependent in experimental glaucoma. Invest. Ophthalmol. Vis. Sci. 32, 484–491.

Gordon, M. O., Beiser, J. A., Brandt, J. D., Heuer, D. K., Higginbotham, E. J., Johnson, C. A., Keltner, J. L., Miller, J. P., Parrish, R. K., 2nd, Wilson, M. R., and Kass, M. A. (2002). The Ocular Hypertension Treatment Study: Baseline factors that predict the onset of primary open angle glaucoma. Arch. Ophthalmol. 120, 714–720.

Grehn, F., Grusser, O. J., and Stange, D. (1984). EVect of short term intraocular pressure increase on cat retinal ganglion cell activity. Behav. Brain Res. 14, 109–121.

Gupta, N., and Yucel, Y. H. (2007). Glaucoma as a neurodegenerative disease. Curr. Opin. Ophthalmol. 18, 110–114.

Hartwick, A. T. (2001). Beyond intraocular pressure: Neuroprotective strategies for future glaucoma therapy. Optom. Vis. Sci. 78, 85–94.

Hartwick, A. T., Lalonde, M. R., Barnes, S., and Baldridge, W. H. (2004). Adenosine A(1) receptor modulation of glutamate induced calcium influx in rat retinal ganglion cells. Invest. Ophthalmol. Vis. Sci. 45, 3740–3748.

Hartwick, A. T., Zhang, X., Chauhan, B. C., and Baldridge, W. H. (2005). Functional assessment of glutamate clearance mechanisms in a chronic rat glaucoma model using retinal ganglion cell calcium imaging. J. Neurochem. 94, 794–807.

Hernandez, M. R. (2000). The optic nerve head in glaucoma: Role of astrocytes in tissue remodeling. Prog. Retin Eye Res. 19, 297–321.

Hof, P. R., Lee, P. Y., Yeung, G., Wang, R. F., Podos, S. M., and Morrison, J. H. (1998). Glutamate receptor subunit GluR2 and NMDAR1 immunoreactivity in the retina of macaque monkeys with experimental glaucoma does not identify vulnerable neurons.

Exp. Neurol. 153, 234–241.

Honkanen, R. A., Baruah, S., Zimmerman, M. B., Khanna, C. L., Weaver, Y. K., Narkiewicz, J., Waziri, R., Gehrs, K. M., Weingeist, T. A., Boldt, H. C., Folk, J. C., Russell, S. R., et al. (2003). Vitreous amino acid concentrations in patients with glaucoma undergoing vitrectomy. Arch. Ophthalmol. 121, 183–188.

Hood, D. C., Xu, L., Thienprasiddhi, P., Greenstein, V. C., Odel, J. G., Grippo, T. M., Liebmann, J. M., and Ritch, R. (2005). The pattern electroretinogram in glaucoma patients with confirmed visual field deficits. Invest. Ophthalmol. Vis. Sci. 46, 2411–2418.

Ishii, K., Kaneda, M., Li, H., Rockland, K. S., and Hashikawa, T. (2003). Neuron specific distribution of P2X7 purinergic receptors in the monkey retina. J. Comp. Neurol. 459, 267–277.

Johnson, E. C., Deppmeier, L. M., Wentzien, S. K., Hsu, I., and Morrison, J. C. (2000). Chronology of optic nerve head and retinal responses to elevated intraocular pressure.

Invest. Ophthalmol. Vis. Sci. 41, 431–442.

Joseph, S. M., Buchakjian, M. R., and Dubyak, G. R. (2003). Colocalization of ATP release sites and ecto ATPase activity at the extracellular surface of human astrocytes. J. Biol. Chem. 278, 23331–23342.

Katz, J., Gilbert, D., Quigley, H. A., and Sommer, A. (1997). Estimating progression of visual field loss in glaucoma. Ophthalmology 104, 1017–1025.

Kawai, S. I., Vora, S., Das, S., Gachie, E., Becker, B., and Neufeld, A. H. (2001). Modeling of risk factors for the degeneration of retinal ganglion cells after ischemia/reperfusion in rats: EVects of age, caloric restriction, diabetes, pigmentation, and glaucoma. FASEB J. 15, 1285–1287.

Kirwan, R. P., Fenerty, C. H., Crean, J., Wordinger, R. J., Clark, A. F., and O’Brien, C. J. (2005). Influence of cyclical mechanical strain on extracellular matrix gene expression in human lamina cribrosa cells in vitro. Mol. Vis. 11, 798–810.

Knepper, P. A., Miller, A. M., Choi, J., Wertz, R. D., Nolan, M. J., Goossens, W., Whitmer, S., Yue, B. Y., Ritch, R., Liebmann, J. M., Allingham, R. R., and Samples, J. R. (2005). Hypophosphorylation of aqueous humor sCD44 and primary open angle glaucoma. Invest. Ophthalmol. Vis. Sci. 46, 2829–2837.

Kolb, H., Linberg, K. A., and Fisher, S. K. (1992). Neurons of the human retina: A Golgi study.

J. Comp. Neurol. 318, 147–187.

Kvanta, A., Seregard, S., Sejersen, S., Kull, B., and Fredholm, B. B. (1997). Localization of adenosine receptor messenger RNAs in the rat eye. Exp. Eye Res. 65, 595–602.

Lam, T. T., Abler, A. S., Kwong, J. M., and Tso, M. O. (1999). N Methyl D aspartate (NMDA) induced apoptosis in rat retina. Invest. Ophthalmol. Vis. Sci. 40, 2391–2397.

Laquis, S., Chaudhary, P., and Sharma, S. C. (1998). The patterns of retinal ganglion cell death in hypertensive eyes. Brain Res. 784, 100–104.

Larsen, A. K., and Osborne, N. N. (1996). Involvement of adenosine in retinal ischemia. Studies on the rat. Invest. Ophthalmol. Vis. Sci. 37, 2603–2611.

Lei, S. Z., Zhang, D., Abele, A. E., and Lipton, S. A. (1992). Blockade of NMDA receptor mediated mobilization of intracellular Ca2þ prevents neurotoxicity. Brain Res. 598, 196–202.

Levin, L., and Gordon, L. (2002). Retinal ganglion cell disorders: Types and treatments. Prog. Retin Eye Res. 21, 465–484.

Levkovitch Verbin, H., Quigley, H. A., Kerrigan Baumrind, L. A., D’Anna, S. A., Kerrigan, D., and Pease, M. E. (2001). Optic nerve transection in monkeys may result in secondary degeneration of retinal ganglion cells. Invest. Ophthalmol. Vis. Sci. 42, 975–982.

Liu, B., and Neufeld, A. H. (2000). Expression of nitric oxide synthase 2 (NOS 2) in reactive astrocytes of the human glaucomatous optic nerve head. Glia 30, 178–186.

Liu, B., and Neufeld, A. H. (2001). Nitric oxide synthase 2 in human optic nerve head astrocytes induced by elevated pressure in vitro. Arch. Ophthalmol. 119, 240–245.

Liu, B., Chen, H., Johns, T. G., and Neufeld, A. H. (2006). Epidermal growth factor receptor activation: An upstream signal for transition of quiescent astrocytes into reactive astrocytes after neural injury. J. Neurosci. 26, 7532–7540.

Lu, W., Reigada, D., Sevigny, J. and Mitchell, C.H. (2007). Stimulation of the P2Y1 receptor upregulates NTPDase1 in human retinal pigment epithelial cells. J. Pharmacol. Exp. Therapeut 323, 157–164.

Lu, W., Rasmussen, C., Gabelt, B., Hennes, B., Kaufman, P., Laties, A. M., and Mitchell, C. H. (2007). Upregulation of NTPDase 1 in an experimental monkey glaucoma model. Invest. Ophthalmol. Vis. Sci. 48, 4804. (abs).

Manabe, S., and Lipton, S. A. (2003). Divergent NMDA signals leading to proapoptotic and antiapoptotic pathways in the rat retina. Invest. Ophthalmol. Vis. Sci. 44, 385–392.

Martin, K. R., Levkovitch Verbin, H., Valenta, D., Baumrind, L., Pease, M. E., and Quigley, H. A. (2002). Retinal glutamate transporter changes in experimental glaucoma and after optic nerve transection in the rat. Invest. Ophthalmol. Vis. Sci. 43, 2236–2243.

Martinez Bello, C., Chauhan, B. C., Nicolela, M. T., McCormick, T. A., and LeBlanc, R. P. (2000). Intraocular pressure and progression of glaucomatous visual field loss. Am. J. Ophthalmol. 129, 302–308.

Maurice, D. M. (1987). Flow of water between aqueous and vitreous compartments in the rabbit eye. Am. J. Physiol. 252, F104–F108.

Mey, J., and Thanos, S. (1993). Intravitreal injections of neurotrophic factors support the survival of axotomized retinal ganglion cells in adult rats in vivo. Brain Res. 602, 304–317.

Minckler, D. S., Bunt, A. H., and Johanson, G. W. (1977). Orthograde and retrograde axoplasmic transport during acute ocular hypertension in the monkey. Invest. Ophthalmol. Vis. Sci. 16, 426–441.

Mitchell, C. H. (2001). Release of ATP by a human retinal pigment epithelial cell line: Potential for autocrine stimulation through subretinal space. J. Physiol. 534, 193–202.

Mitchell, C. H. (2008). P2X7 receptor kills retinal ganglion cells with glutamate release and excitotoxic NMDA receptor activation. Purinergic Signalling 2, Supp 1.

Mitchell, C. H., Carre, D. A., McGlinn, A. M., Stone, R. A., and Civan, M. M. (1998). A release mechanism for stored ATP in ocular ciliary epithelial cells. Proc. Natl. Acad. Sci. USA 95, 7174–7178.

Mitchell, C. H., Zhang, M., Zhang, X., Lu, W., Reigada, D., and Laties, A. M. (2006). Neuronal death evoked by the P2X7 receptor mediated by the NMDA receptor. Invest. Ophthalmol. Vis. Sci. 47, 2589. (abs).

Morgan, J. E. (2000). Optic nerve head structure in glaucoma: Astrocytes as mediators of axonal damage. Eye 14, 437–444.

Morgan, J. E. (2002). Retinal ganglion cell shrinkage in glaucoma. J. Glaucoma 11, 365–370. Morgan, J. E., Uchida, H., and Caprioli, J. (2000). Retinal ganglion cell death in experimental

glaucoma. Br. J. Ophthalmol. 84, 303–310.

Morrison, J. C., Johnson, E. C., Cepurna, W., and Jia, L. (2005). Understanding mechanisms of pressure induced optic nerve damage. Prog. Retin Eye Res. 24, 217–240.

Naskar, R., Vorwerk, C. K., and Dreyer, E. B. (2000). Concurrent downregulation of a glutamate transporter and receptor in glaucoma. Invest. Ophthalmol. Vis. Sci. 41, 1940–1944.

Neufeld, A. H. (2004). Pharmacologic neuroprotection with an inhibitor of nitric oxide synthase for the treatment of glaucoma. Brain Res. Bull. 62, 455–459.

Neufeld, A. H., and Liu, B. (2003). Glaucomatous optic neuropathy: When glia misbehave.

Neuroscientist 9, 485–495.

Neufeld, A. H., Sawada, A., and Becker, B. (1999). Inhibition of nitric oxide synthase 2 by aminoguanidine provides neuroprotection of retinal ganglion cells in a rat model of chronic glaucoma. Proc. Natl. Acad. Sci. USA 96, 9944–9948.

Newman, E. A. (2001). Propagation of intercellular calcium waves in retinal astrocytes and Muller cells. J. Neurosci. 21, 2215–2223.

Newman, E. A. (2003). Glial cell inhibition of neurons by release of ATP. J. Neurosci. 23, 1659–1666.

Ogden, T. E., Duggan, J., Danley, K., Wilcox, M., and Minckler, D. S. (1988). Morphometry of nerve fiber bundle pores in the optic nerve head of the human. Exp. Eye Res. 46, 559–568.

Osborne, N. N., Ugarte, M., Chao, M., Chidlow, G., Bae, J. H., Wood, J. P., and Nash, M. S. (1999a). Neuroprotection in relation to retinal ischemia and relevance to glaucoma. Surv. Ophthalmol. 43, S102–S128.

Osborne, N. N., Wood, J. P., Chidlow, G., Bae, J. H., Melena, J., and Nash, M. S. (1999b). Ganglion cell death in glaucoma: What do we really know? Br. J. Ophthalmol. 83, 980–986.

Osborne, N. N., Melena, J., Chidlow, G., and Wood, J. P. (2001). A hypothesis to explain ganglion cell death caused by vascular insults at the optic nerve head: Possible implication for the treatment of glaucoma. Br. J. Ophthalmol. 85, 1252–1259.

Osborne, N. N., Chidlow, G., Wood, J., and Casson, R. (2003). Some current ideas on the pathogenesis and the role of neuroprotection in glaucomatous optic neuropathy. Eur. J. Ophthalmol. 13, S19–S26.

Pang, I. H., Johnson, E. C., Jia, L., Cepurna, W. O., Shepard, A. R., Hellberg, M. R., Clark, A. F., and Morrison, J. C. (2005). Evaluation of inducible nitric oxide synthase in glaucomatous optic neuropathy and pressure induced optic nerve damage. Invest. Ophthalmol. Vis. Sci. 46, 1313–1321.

Pease, M. E., McKinnon, S. J., Quigley, H. A., Kerrigan Baumrind, L. A., and Zack, D. J. (2000). Obstructed axonal transport of BDNF and its receptor TrkB in experimental glaucoma. Invest. Ophthalmol. Vis. Sci. 41, 764–774.

Peers, C., Kang, P., Boyle, J. P., Porter, K. E., Pearson, H. A., Smith, I. F., and Kemp, P. J. (2006). Hypoxic regulation of Ca2þ signalling in astrocytes and endothelial cells. Novartis Found. Symp. 272, 119–127.

Pereira, M. L., Kim, C. S., Zimmerman, M. B., Alward, W. L., Hayreh, S. S., and Kwon, Y. H. (2002). Rate and pattern of visual field decline in primary open angle glaucoma. Ophthalmology 109, 2232–2240.

Porciatti, V., Saleh, M., and Nagaraju, M. (2007). The pattern electroretinogram as a tool to monitor progressive retinal ganglion cell dysfunction in the DBA/2J mouse model of glaucoma. Invest. Ophthalmol. Vis. Sci. 48, 745–751.

Puthussery, T., and Fletcher, E. L. (2004). Synaptic localization of P2X7 receptors in the rat retina. J. Comp. Neurol. 472, 13–23.

Quigley, H. A. (1996). Number of people with glaucoma worldwide. Br. J. Ophthalmol. 80, 389–393.

Quigley, H. A., and Addicks, E. M. (1981). Regional diVerences in the structure of the lamina cribrosa and their relation to glaucomatous optic nerve damage. Arch. Ophthalmol. 99, 137–143.

Quigley, H. A., and Green, W. R. (1979). The histology of human glaucoma cupping and optic nerve damage: Clinicopathologic correlation in 21 eyes. Ophthalmology 86, 1803–1830.

Quigley, H. A., Flower, R. W., Addicks, E. M., and McLeod, D. S. (1980). The mechanism of optic nerve damage in experimental acute intraocular pressure elevation. Invest. Ophthalmol. Vis. Sci. 19, 505–517.

Quigley, H. A., Addicks, E. M., Green, W. R., and Maumenee, A. E. (1981). Optic nerve damage in human glaucoma. II. The site of injury and susceptibility to damage. Arch. Ophthalmol. 99, 635–649.

Quigley, H. A., Hohman, R. M., Addicks, E. M., Massof, R. W., and Green, W. R. (1983). Morphologic changes in the lamina cribrosa correlated with neural loss in open angle glaucoma. Am. J. Ophthalmol. 95, 673–691.

Quigley, H. A., Sanchez, R. M., Dunkelberger, G. R., L’Hernault, N. L., and Baginski, T. A. (1987). Chronic glaucoma selectively damages large optic nerve fibers. Invest. Ophthalmol. Vis. Sci. 28, 913–920.

Quigley, H. A., McKinnon, S. J., Zack, D. J., Pease, M. E., Kerrigan Baumrind, L. A., Kerrigan, D. F., and Mitchell, R. S. (2000). Retrograde axonal transport of BDNF in retinal ganglion cells is blocked by acute IOP elevation in rats. Invest. Ophthalmol. Vis. Sci. 41, 3460–3466.

Robson, S. C., Se´vigny, J., and Zimmermann, H. (2006). The E NTPDase family of ectonucleotidases: Structure, function, relationships and pathophysiological significance. Purinergic Signal. 2, 409–430.

Roth, S., Park, S. S., Sikorski, C. W., Osinski, J., Chan, R., and Loomis, K. (1997a). Concentrations of adenosine and its metabolites in the rat retina/choroid during reperfusion after ischemia. Curr. Eye Res. 16, 875–885.

Roth, S., Rosenbaum, P. S., Osinski, J., Park, S. S., Toledano, A. Y., Li, B., and Moshfeghi, A. A. (1997b). Ischemia induces significant changes in purine nucleoside concentration in the retina choroid in rats. Exp. Eye Res. 65, 771–779.

Sawada, A., and Neufeld, A. H. (1999). Confirmation of the rat model of chronic, moderately elevated intraocular pressure. Exp. Eye Res. 69, 525–531.

Schulte, G., and Fredholm, B. B. (2002). Signaling pathway from the human adenosine A(3) receptor expressed in Chinese hamster ovary cells to the extracellular signal regulated kinase 1/2. Mol. Pharmacol. 62, 1137–1146.

Sehi, M., Flanagan, J. G., Zeng, L., Cook, R. J., and Trope, G. E. (2005). Relative change in diurnal mean ocular perfusion pressure: A risk factor for the diagnosis of primary open angle glaucoma. Invest. Ophthalmol. Vis. Sci. 46, 561–567.

Sigal, I. A., Flanagan, J. G., and Ethier, C. R. (2005). Factors influencing optic nerve head biomechanics. Invest. Ophthalmol. Vis. Sci. 46, 4189–4199.

Sucher, N. J., Wong, L. A., and Lipton, S. A. (1990). Redox modulation of NMDA receptor mediated Ca2þ flux in mammalian central neurons. Neuroreport 1, 29–32.

Sucher, N. J., Lei, S. Z., and Lipton, S. A. (1991). Calcium channel antagonists attenuate NMDA receptor mediated neurotoxicity of retinal ganglion cells in culture. Br. Res. 551, 297–302.

Sullivan, R. K., Woldemussie, E., Macnab, L., Ruiz, G., and Pow, D. V. (2006). Evoked expression of the glutamate transporter GLT 1c in retinal ganglion cells in human glaucoma and in a rat model. Invest. Ophthalmol. Vis. Sci. 47, 3853–3859.

Sun, X., Barnes, S., and Baldridge, W. H. (2002). Adenosine inhibits calcium channel currents via A1 receptors on salamander retinal ganglion cells in a mini slice preparation. J. Neurochem. 81, 550–556.

Sun, D., Rait, J. L., and Kalloniatis, M. (2003). Inner retinal neurons display diVerential responses to N methyl D aspartate receptor activation. J. Comp. Neurol. 465, 38–56.

Surprenant, A., Rassendren, F., Kawashima, E., North, R. A., and Buell, G. (1996). The cytolytic P2Z receptor for extracellular ATP identified as a P2X receptor (P2X7). Science 272, 735–738.

Swanson, R. A., Farrell, K., and Simon, R. P. (1995). Acidosis causes failure of astrocyte glutamate uptake during hypoxia. J. Cereb. Blood Flow Metab. 15, 417–424.

Tezel, G. (2006). Oxidative stress in glaucomatous neurodegeneration: Mechanisms and consequences. Prog. Retin Eye Res. 25, 490–513.

Tezel, G., Siegmund, K. D., Trinkaus, K., Wax, M. B., Kass, M. A., and Kolker, A. E. (2001). Clinical factors associated with progression of glaucomatous optic disc damage in treated patients. Arch. Ophthalmol. 119, 813–818.

Ullian, E. M., Barkis, W. B., Chen, S., Diamond, J. S., and Barres, B. A. (2004). Invulnerability of retinal ganglion cells to NMDA excitotoxicity. Mol. Cell Neurosci. 26, 544–557.

Varela, H. J., and Hernandez, M. R. (1997). Astrocyte responses in human optic nerve head with primary open angle glaucoma. J. Glaucoma 6, 303–313.

Ventura, L. M., and Porciatti, V. (2005). Restoration of retinal ganglion cell function in early glaucoma after intraocular pressure reduction: A pilot study. Ophthalmology 112, 20–27.

Ventura, L. M., Sorokac, N., De Los Santos, R., Feuer, W. J., and Porciatti, V. (2006). The relationship between retinal ganglion cell function and retinal nerve fiber thickness in early glaucoma. Invest. Ophthalmol. Vis. Sci. 47, 3904–3911.

Vorwerk, C. K., Kreutz, M. R., Bockers, T. M., Brosz, M., Dreyer, E. B., and Sabel, B. A. (1999). Susceptibility of retinal ganglion cells to excitotoxicity depends on soma size and retinal eccentricity. Curr. Eye Res. 19, 59–65.

Votruba, M. (2004). Molecular genetic basis of primary inherited optic neuropathies. Eye 18, 1126–1132.

Wax, M. B., and Tezel, G. (2002). Neurobiology of glaucomatous optic neuropathy: Diverse cellular events in neurodegeneration and neuroprotection. Mol. Neurobiol. 26, 45–55.

Weber, A. J., Kaufman, P. L., and Hubbard, W. C. (1998). Morphology of single ganglion cells in the glaucomatous primate retina. Invest. Ophthalmol. Vis. Sci. 39, 2304–2320.

Weinstein, G. W., Arden, G. B., Hitchings, R. A., Ryan, S., Calthorpe, C. M., and Odom, J. V. (1988). The pattern electroretinogram (PERG) in ocular hypertension and glaucoma. Arch. Ophthalmol. 106, 923–928.

WoldeMussie, E., Yoles, E., Schwartz, M., Ruiz, G., and Wheeler, L. A. (2002). Neuroprotective eVect of memantine in diVerent retinal injury models in rats. J. Glaucoma 11, 474–480.

WoldeMussie, E., Wijono, M., and Ruiz, G. (2004). Muller cell response to laser induced increase in intraocular pressure in rats. Glia 47, 109–119.

Yoles, E., and Schwartz, M. (1998). Potential neuroprotective therapy for glaucomatous optic neuropathy. Surv. Ophthalmol. 42, 367–372.

Zhang, X., Zhang, M., Laties, A. M., and Mitchell, C. H. (2005). Stimulation of P2X7 receptors elevates Ca2þ and kills retinal ganglion cells. Invest. Ophthalmol. Vis. Sci. 46, 2183–2191.

Zhang, M., Budak, M. T., Lu, W., Khurana, T. S., Zhang, X., Laties, A. M., and Mitchell, C. H. (2006a). Identification of the A3 adenosine receptor in rat retinal ganglion cells. Mol. Vis. 12, 937–948.

Zhang, X., Zhang, M., Laties, A. M., and Mitchell, C. H. (2006b). Balance of purines may determine life or death as A3 adenosine receptors prevent loss of retinal ganglion cells following P2X7 receptor stimulation. J. Neurochem. 98, 566–575.

Zhang, X., Reigada, D., Zhang, M., Laties, A. M., and Mitchell, C. H. (2006c). Increased ocular pressure increases vitreal levels of ATP. Invest. Ophthalmol. Vis. Sci. 47, 426. (abs).

Zhang, X., Li, A., Ge, J., Reigada, D., Laties, A. M., and Mitchell, C. H. (2007). Acute increase of intraocular pressure releases ATP into the anterior chamber. Exp. Eye Res. 85, 637–643.

Zhou, Y., Pernet, V., Hauswirth, W. W., and Di Polo, A. (2005). Activation of the extracellular signal regulated kinase 1/2 pathway by AAV gene transfer protects retinal ganglion cells in glaucoma. Mol. Ther. J. Am. Soc. Gene Ther. 12, 402–412.